Treatment support device, program, and treatment support method
Patent Information
- Application Number
- JP2023140035
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2023-08-30
- Publication Date
- 2025-03-13
AI Technical Summary
【0020】 本発明の一態様によれば、薬物治療の効果を従来よりも高めることができる。
Smart Images

Figure 2025033958000001_ABST
Abstract
Description
[Technical field]
[0001] The present invention relates to a treatment support device, a program, and a treatment support method used in drug treatment. [Background technology]
[0002] In recent years, various technologies have been developed for supporting medical treatment, particularly for supporting drug treatment. For example, Patent Document 1 discloses a technology that determines the appropriateness of a current medical treatment plan based on a medical treatment guideline and patient information including the patient's biological information and medication information, and generates and outputs recommended medical treatment information according to the determination result. The recommended medical treatment information is information that indicates measures that are recommended to be taken for the patient. [Prior art documents] [Patent documents]
[0003] [Patent Document 1] JP 2023-10391 A Summary of the Invention [Problem to be solved by the invention]
[0004] However, the technology disclosed in Patent Document 1 may generate and output recommended treatment information indicating changes in types and combinations of medicines, measures other than medication, changes in treatment plans, etc. In such cases, even if a patient receives an explanation of the recommended treatment information from a doctor during a consultation, the patient may not understand the contents, making it difficult for the patient to be convinced to receive treatment based on the recommended treatment information. This causes the patient to have a negative attitude toward receiving treatment based on the recommended treatment information, which in turn reduces the effectiveness of treatment based on the recommended treatment information.
[0005] One aspect of the present invention has been made in consideration of the above problems, and has as its object to improve the effect of drug therapy more than ever before. [Means for solving the problem]
[0006] In order to solve the above problems, a treatment support device according to one embodiment of the present invention comprises a decision unit that determines the adjustment content of the medication dosage by acquiring patient information including the patient's biometric information and the actual dosage of the medication prescribed to the patient, and a display control unit that displays the decision result of the decision unit on a patient side display unit, which is a display unit of a terminal used by the patient.
[0007] According to the above configuration, since the adjustment of the dosage of the medicine is displayed on the patient-side display unit, the patient can easily understand how to adjust the dosage by simply viewing the patient-side display unit even before consulting a doctor. This lowers the psychological hurdle for the patient in taking the medicine. In addition, it is easy to motivate the patient to communicate with the doctor by consulting about the adjustment of the dosage. Therefore, the patient's attitude toward receiving drug treatment can be improved to a more positive one, and the effect of drug treatment can be improved more than before.
[0008] In one aspect of the treatment support device of the present invention, the display control unit may further display, on the patient-side display unit, the actual dosage and a target dosage of the medication set for the patient, and may vary the display manner of the actual dosage on the patient-side display unit depending on whether the actual dosage has reached the target dosage.
[0009] According to the above configuration, the actual dose and the target dose are displayed in different display modes depending on whether the target dose has been reached or not on the patient-side display unit. This allows the patient to easily understand whether the dose needs to be adjusted, which is the premise for the dosage adjustment, simply by looking at the patient-side display unit. This makes it even easier to motivate the patient to receive a medical examination regarding the dosage adjustment.
[0010] In the treatment support device according to one aspect of the present invention, the display control unit may also cause a doctor's display unit, which is a display unit of a terminal used by the doctor, to display the determination result.
[0011] According to the above configuration, while both the patient and the doctor are viewing the doctor's display unit during the consultation, the patient can receive detailed explanations from the doctor regarding the dosage adjustment contents that are the same as those displayed on the patient's display unit. Since the patient can view the patient's display unit even before the consultation, the patient can grasp at least the outline of the dosage adjustment contents in advance. Therefore, the patient can understand the dosage adjustment contents more quickly and deeply by undergoing a consultation. This makes it easier to motivate the patient to undergo a consultation regarding the dosage adjustment contents.
[0012] In the treatment support device according to one aspect of the present invention, the display control unit may cause the biological information to be displayed on both the patient-side display unit and the doctor-side display unit.
[0013] According to the above configuration, the patient can understand the dosage adjustment contents in association with the patient's biological information simply by viewing the patient-side display unit. Furthermore, when the doctor examines the patient, the doctor can explain the dosage adjustment contents in detail to the patient while associating them with the patient's biological information displayed on the doctor-side display unit. Therefore, the patient can understand the importance of dosage adjustments more quickly and deeply by receiving a medical examination. This makes it even easier to motivate the patient to receive a medical examination regarding the dosage adjustment contents.
[0014] In a treatment support device according to one aspect of the present invention, the display control unit may convert the determination result into content suitable for presentation to the patient and display the content on the patient-side display unit.
[0015] According to the above configuration, the patient can easily understand the contents of the determination result determined by the determination unit by visually checking the determination result displayed on the patient-side display unit. In addition, if the determination result determined by the determination unit includes contents that are not desirable to be conveyed to the patient, the contents can be hidden, for example, on the patient-side display unit. This further lowers the psychological hurdle for the patient to receive a consultation regarding dosage adjustment, making it easier to motivate the patient to receive the consultation.
[0016] In the treatment support device according to an aspect of the present invention, the biological information may include blood information of the patient. According to the above configuration, the determination unit can determine the dosage adjustment content based on the biological information including the patient's blood information. This makes it possible to use the treatment support device according to an aspect of the present invention for diseases such as heart failure that require the patient's blood information to determine the dosage adjustment content. Therefore, even if the patient has a disease such as heart failure, the patient's attitude toward drug treatment can be improved to a more positive one.
[0017] In the treatment support device according to one aspect of the present invention, the patient information may further include a patient-reported outcome of the patient. According to the above configuration, the determination unit can determine the dosage adjustment content based on the patient information including the patient-reported outcome of the patient. This allows the patient's subjective indicators to be taken into account when determining the dosage adjustment content, thereby increasing the patient's satisfaction with the determination result of the determination unit. This increases the patient's motivation to receive a consultation regarding the dosage adjustment, making it even easier to motivate the patient to receive the consultation.
[0018] In order to solve the above problems, a therapeutic support method according to one aspect of the present invention includes a determination step of determining the adjustment of the dosage of the drug by acquiring patient information including the patient's biological information and the actual dosage of the drug prescribed to the patient, and a display control step of displaying the result of the determination step on a patient-side display unit which is a display unit of a terminal used by the patient. According to the above configuration, a therapeutic support method capable of improving the effect of drug therapy more than ever before can be realized.
[0019] The treatment support device according to each aspect of the present invention may be realized by a computer. In this case, the treatment support device program that causes the computer to operate as each unit (software element) of the treatment support device to realize the treatment support device, and the computer-readable recording medium on which the program is recorded, also fall within the scope of the present invention. Effect of the Invention
[0020] According to one aspect of the present invention, the effect of drug therapy can be improved more than ever before. [Brief description of the drawings]
[0021] [Figure 1] 1 is a block diagram showing a functional configuration of a treatment support system according to an embodiment of the present invention. [Diagram 2] 1 is a flowchart showing a flow of a treatment support method according to an embodiment of the present invention. [Diagram 3] Reference numeral 301 is a diagram showing an example of a basic information input screen, and reference numeral 302 is a diagram showing an example of a dosage input screen. [Figure 4] Reference numeral 401 is a diagram showing an example of a biometric information input screen before data input, and reference numeral 402 is a diagram showing an example of a biometric information input screen after data input. [Diagram 5] Reference numeral 501 is a diagram showing an example of a medication status display screen, and reference numeral 502 is a diagram showing another example of the medication status display screen. [Figure 6] FIG. 13 is a diagram showing an example of a biological information transition screen. [Figure 7] Reference numerals 701 to 703 show an example of screen transition during the process of switching from the patient mode to the examination mode. [Figure 8] Reference numeral 801 is a diagram showing an example of a blood information input screen before data input, reference numeral 802 is a diagram showing an example of an adjustment content display screen, and reference numeral 803 is a diagram showing an example of a dosage input screen after data input. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0022] [Configuration of treatment support system] The configuration of a treatment support system 100 according to one embodiment of the present invention will be described with reference to FIG. 1. The treatment support system 100 is a system that supports drug treatment for a patient. In this embodiment, the treatment support system 100 will be described as a system that supports drug treatment for heart failure. However, there is no particular limitation on the type of disease that the treatment support system 100 supports, and the treatment support system 100 supports all diseases that can be treated with drugs. As shown in FIG. 1, the treatment support system 100 is composed of a patient terminal 1, a doctor terminal 2, and a server 3.
[0023] <Patient's terminal> The patient terminal 1 is a terminal used by a patient, and is, for example, a smartphone, a tablet terminal, or a stationary personal computer. In this embodiment, the patient terminal 1 is described as being a smartphone. The patient terminal 1 includes an input unit 11, a patient display unit 12, a storage unit 13, a communication unit 14, and a control unit 15.
[0024] The input unit 11 is an interface that accepts various operations by the patient. The patient-side display unit 12 is a display unit of the patient-side terminal 1, and is an output unit that displays various information. In this embodiment, the patient-side terminal 1 is equipped with a touch panel in which the input unit 11 and the patient-side display unit 12 are integrated.
[0025] The storage unit 13 stores various information used by the patient-side terminal 1. Examples of the storage unit 13 include a RAM (Random Access Memory) and a flash memory. The communication unit 14 is a unit that allows the patient-side terminal 1 to transmit and receive various information between the doctor-side terminal 2 and the server 3. The control unit 15 is, for example, a CPU (Central Processing Unit) or a GPU (Graphics Processing Unit), and controls each unit of the patient-side terminal 1. The control unit 15 also executes processes for implementing various functions provided by the patient-side terminal 1.
[0026] In this embodiment, the treatment support device 16 is built into the control unit 15. The treatment support device 16 may be provided outside the control unit 15 in the patient terminal 1. Alternatively, the treatment support device 16 may be built into the doctor terminal 2 or the server 3, or may be built into an information processing device (not shown) other than the doctor terminal 2 and the server 3.
[0027] The treatment support device 16 includes a determination unit 161 and a patient-side display control unit 162 (display control unit). The determination unit 161 acquires patient information including the patient's biological information and the actual dosage of the medicine prescribed to the patient, thereby determining the adjustment content of the medicine dosage. The details of the adjustment content will be described later. The biological information is, for example, the patient's body temperature, pulse, blood pressure, weight, brainwaves, respiratory rate, and pupillary reflex. In this embodiment, the biological information includes the patient's blood information. The blood information is, for example, the patient's serum creatinine (Cre) value and serum potassium value.
[0028] In this embodiment, the patient is prescribed three basic drugs for heart failure. The three basic drugs for heart failure are ACE (angiotensin-converting enzyme) inhibitor / ARB (angiotensin receptor blocker) / ARNI (angiotensin receptor neprilysin inhibitor), β-blocker, and MRA (mineralocorticoid receptor antagonist). An example of the ACE inhibitor is enalapril, an example of the β-blocker is carvedilol, and an example of the MRA is spironolactone.
[0029] The patient display control unit 162 causes the patient display unit 12 to display the result of the determination by the determination unit 161, that is, the adjustment of the drug dosage. In this embodiment, the patient display control unit 162 also causes the patient display unit 12 to display the actual dosage and the target dosage of the drug set for the patient. The patient display control unit 162 then changes the display mode of the actual dosage on the patient display unit 12 depending on whether the actual dosage has reached the target dosage. The details of changing the display mode will be described later. Furthermore, in this embodiment, the patient display control unit 162 also causes the doctor display unit 22, which will be described later, to display the result of the determination by the determination unit 161. The details of the display control by the patient display control unit 162 will be described later.
[0030] <Doctor's terminal> The doctor's terminal 2 is a terminal used by a doctor, and is, for example, a smartphone, a tablet terminal, or a stationary personal computer. In this embodiment, the doctor's terminal 2 is also described as a smartphone. The doctor's terminal 2 includes an input unit 21, a doctor's display unit 22, a storage unit 23, a communication unit 24, and a control unit 25.
[0031] The input unit 21 is an interface that accepts various operations by the doctor. The doctor-side display unit 22 is a display unit of the doctor-side terminal 2, and is an output unit that displays various information. The memory unit 23 stores various information used by the doctor-side terminal 2. The communication unit 24 is a unit that enables the doctor-side terminal 2 to send and receive various information between the patient-side terminal 1 and the server 3. The control unit 25 comprehensively controls each unit of the doctor-side terminal 2. The control unit 25 also executes processing to realize various functions possessed by the doctor-side terminal 2. The control unit 25 has a doctor-side display control unit 251 built in. The doctor-side display control unit 251 controls the display of the doctor-side display unit 22.
[0032] <Server> The server 3 is a communication device capable of transmitting and receiving between the patient terminal 1 and the doctor terminal 2. The server 3 may be wirelessly connected to both the patient terminal 1 and the doctor terminal 2, or may be wired to either the patient terminal 1 or the doctor terminal 2. The server 3 includes a storage unit 31, a communication unit 32, and a control unit 33. The storage unit 31 stores various information used by the server 3. In this embodiment, the storage unit 31 stores patient information of multiple patients in a database. The communication unit 32 is a unit for the server 3 to transmit and receive various information between the patient terminal 1 and the doctor terminal 2. The control unit 33 controls each unit of the server 3. The control unit 33 also executes processes for implementing various functions provided by the server 3.
[0033] The server 3 is not an essential component of the treatment support system 100, and the treatment support system 100 may be composed of the patient terminal 1 and the doctor terminal 2. Furthermore, in order to embody the technical idea of the present invention, neither the server 3 nor the doctor terminal 2 are essential components. In other words, the technical idea of the present invention can be embodied by only the patient terminal 1 equipped with the patient display unit 12 and the treatment support device 16.
[0034] [Treatment support method using treatment support system] A medical treatment support method using the medical treatment support system 100 will be described with reference to FIGS.
[0035] <s101> 2, the determination unit 161 acquires patient information (first patient information acquisition step). The first patient information acquisition step is an example of the determination step included in the medical treatment support method according to an aspect of the present invention.
[0036] Specifically, the input unit 11 accepts an input operation of a patient from the initial setting screen shown in Fig. 3, and transmits the input patient information to the determination unit 161. Then, the determination unit 161 receives the patient information transmitted from the input unit 11, and thereby acquires the patient information.
[0037] The initial setting screen is a screen displayed on the patient display unit 12 when the display mode of the patient terminal 1 is the initial setting mode. The initial setting screen displayed first in the initial setting mode is a basic information input screen 121, indicated by reference numeral 301 in FIG. 3. The basic information input screen 121 automatically displays the date of input, and also has fields for "patient identification ID," "gender," "birthday (date of birth)," "most recent Cre (creatinine level)," "most recent K (serum potassium level)," and "most recent blood sampling date," which constitute the patient's basic information. The patient's basic information is input to the input unit 11 by performing input operations in these fields.
[0038] After the input of the patient's basic information is completed, when the input unit 11 accepts a pressing operation of a screen transition button 1211 provided on the basic information input screen 121, the initial setting screen transitions from the basic information input screen 121 to a dosage input screen 122 shown by reference numeral 302 in Fig. 3. That is, when the input unit 11 accepts a pressing operation of the screen transition button 1211, the patient-side display control unit 162 transitions the display of the patient-side display unit 12 from the basic information input screen 121 to the dosage input screen 122. Note that in this embodiment, the pressing operation of a button or the like displayed on the patient-side display unit 12 refers to tapping on the display area of the button or the like on the patient-side display unit 12.
[0039] The dosage input screen 122 has a field for selecting a specific type of drug name for each of ACE inhibitors / ARBs / ARNIs, β-blockers, and MRAs, and then inputting the current (as of the input date) actual dosage (hereinafter abbreviated as "dose"). In this embodiment, the input unit 11 accepts a pressing operation of each of the name buttons 1223 to 1225 of the three basic drugs for heart failure, and the patient-side display control unit 162 displays a menu 1226 corresponding to each of the three basic drugs in the lower end area of the dosage input screen 122. The menu 1226 is, for example, a drum roll type select box, and displays multiple types of names of drugs belonging to each of the three basic drugs. Then, the input unit 11 accepts a selection operation of any of the drug names displayed in the menu 1226, and the patient-side display control unit 162 displays the selected drug name in the drug name fields 1227 to 1229 corresponding to each of the three basic drugs.
[0040] The example of reference numeral 302 in Fig. 3 is an example in which a menu 1226 displaying the names of multiple types of drugs belonging to ACE inhibitors / ARBs / ARNIs is displayed. Also, the example of reference numeral 302 in Fig. 3 is an example in which "enalapril" is selected from multiple types of drugs belonging to ACE inhibitors / ARBs / ARNIs, "carvedilol" is selected from multiple types of drugs belonging to β-blockers, and "spironolactone" is selected from multiple types of drugs belonging to MRAs. Furthermore, the dosages of the three basic drugs are input to the input unit 11 by the patient performing an input operation in the fields for inputting the dosage of each drug.
[0041] After the dosage input is completed, when the input unit 11 accepts a pressing operation of the decision button 1221 provided on the dosage input screen 122, the content of the patient information acquired by the decision unit 161 is confirmed. The "content of the patient information" here refers to the basic information of the patient and the dosages of the three basic drugs for heart failure input to the input unit 11. After the patient information is confirmed, the decision unit 161 receives the patient information transmitted from the input unit 11, and thereby acquires the patient information.
[0042] Furthermore, when the input unit 11 accepts a pressing operation of the decision button 1221, the display mode of the patient-side terminal 1 is switched from the initial setting mode to the patient mode. When the display mode of the patient-side terminal 1 is switched to the patient mode, the process proceeds to S102.
[0043] On the other hand, when the input unit 11 accepts a pressing operation of the screen transition button 1222 provided on the dosage input screen 122 during or after the input of the dosage, the initial setting screen transitions again from the dosage input screen 122 to the basic information input screen 121. In other words, when the input unit 11 accepts a pressing operation of the screen transition button 1222, the patient-side display control unit 162 transitions the display of the patient-side display unit 12 from the dosage input screen 122 back to the basic information input screen 121. This allows the patient to modify the basic information of the patient that was once input from the basic information input screen 121.
[0044] <s102> Next, in S102, the decision unit 161 acquires patient information again (second patient information acquisition step). The second patient information acquisition step is an example of the decision step included in the treatment support method according to one aspect of the present invention. Specifically, the input unit 11 accepts an input operation of the patient from the biological information input screen 123 shown in FIG. 4, thereby transmitting the input patient information to the decision unit 161 and the patient side display control unit 162. Then, the decision unit 161 and the patient side display control unit 162 receive the patient information transmitted from the input unit 11, thereby acquiring the patient information.
[0045] The bioinformation input screen 123 is a screen that is first displayed on the patient display unit 12 when the display mode of the patient terminal 1 is the patient mode. The bioinformation input screen 123 automatically displays the date and time of the input date, and also has columns for "systolic blood pressure value," "diastolic blood pressure value," "pulse," and "weight," which constitute the patient's bioinformation. The "systolic blood pressure value" refers to the systolic blood pressure value, and the "diastolic blood pressure value" refers to the diastolic blood pressure value. The patient's bioinformation is input to the input unit 11 by the patient performing an input operation in these columns. That is, the patient information acquired by the determination unit 161 and the patient display control unit 162 in S102 is the patient's bioinformation input from each column of the bioinformation input screen 123. The bioinformation input screen 123 also has a column for "medication on the previous day" for inputting whether or not the patient took medication on the day before the input date.
[0046] Upon receiving the patient information transmitted from the input unit 11, the patient-side display control unit 162 causes the patient-side display unit 12 to display the input contents on the bioinformation input screen 123, as shown by reference numeral 402 in Fig. 4. In this embodiment, when the input unit 11 accepts an input operation once a day in each field of the bioinformation input screen 123, the control unit 15 controls the acceptance process of the input unit 11 so that the input unit 11 does not accept a second or subsequent input operation on the same day.
[0047] The lower end area of the bioinformation input screen 123 is provided with a first screen transition button 1231, a second screen transition button 1232, and a third screen transition button 1233. When the input unit 11 accepts a pressing operation of the first screen transition button 1231 in a case where the display mode of the patient side terminal 1 is the patient mode, the patient side display control unit 162 transitions the display of the patient side display unit 12 to the bioinformation input screen 123. When the input unit 11 accepts a pressing operation of the second screen transition button 1232, the patient side display control unit 162 transitions the display of the patient side display unit 12 to a medication status display screen 124 described later. When the input unit 11 accepts a pressing operation of the third screen transition button 1233, the patient side display control unit 162 transitions the display of the patient side display unit 12 to a bioinformation transition screen 125 described later.
[0048] Here, the biological information input screen 123, the medication status display screen 124, and the biological information transition screen 125 constitute a patient mode screen. The patient mode screen is a collective term for the above three types of screens displayed on the patient display unit 12 when the display mode of the patient terminal 1 is the patient mode.
[0049] The first to third screen transition buttons 1231 to 1233 are also displayed in the bottom region of the medication status display screen 124 (see FIG. 5) and in the bottom region of the biological information transition screen 125 (see FIG. 6). Furthermore, when the biological information input screen 123 is displayed, the patient-side display control unit 162 highlights the first screen transition button 1231 on the patient-side display unit 12. Similarly, the patient-side display control unit 162 highlights the second screen transition button 1232 when the medication status display screen 124 is displayed, and highlights the third screen transition button 1233 when the biological information transition screen 125 is displayed.
[0050] 4, when the input unit 11 accepts a pressing operation of the second screen transition button 1232 or the third screen transition button 1233, the display on the patient-side display unit 12 transitions to either the medication status display screen 124 or the biological information transition screen 125. In the example of the reference numeral 402 in FIG. 4, it is assumed that the input unit 11 accepts a pressing operation of the second screen transition button 1232.
[0051] When the input unit 11 accepts the pressing operation of the second screen transition button 1232, the display of the patient-side display unit 12 transitions from the biological information input screen 123 to the medication status display screen 124 shown in Fig. 5. The medication status display screen 124 has a column for each medicine that the patient is actually taking, and in this embodiment, columns for ACE inhibitors / ARBs / ARNIs, β-blockers, and MRAs are provided.
[0052] In addition, the actual dose and the target dose are displayed in each of the columns for ACE inhibitors / ARBs / ARNIs, β-blockers, and MRAs. In the example of reference numeral 501 in FIG. 5, for example, in the column for ACE inhibitors / ARBs / ARNIs, the actual dose is displayed as "5.0 mg" and the target dose is displayed as "5 to 10 mg." In addition, in the example of reference numeral 502 in FIG. 5, for example, in the column for β-blockers, the actual dose is displayed as "2.5 mg" and the target dose is displayed as "5 to 20 mg."
[0053] Furthermore, in this embodiment, the proportion of the actual dosage when the maximum target dosage is set to "1" is displayed in the form of a bar graph on the dosage status display screen 124. That is, in this embodiment, the patient-side display control unit 162 causes the patient-side display unit 12 to display the proportion of the actual dosage when the maximum target dosage is set to "1" in the form of a bar graph. In the following description, for convenience, the display portion in the form of the bar graph described above will be referred to as a "bar graph." When the actual dose reaches the target dose, the patient-side display control unit 162 controls the patient-side display unit 12 to display the portion of the bar graph displaying the actual dose in yellow-green, as shown by reference numeral 501 in Fig. 5. On the other hand, when the actual dose does not reach the target dose, the patient-side display control unit 162 controls the patient-side display unit 12 to display the portion of the bar graph displaying the actual dose in yellow, as shown by reference numeral 502 in Fig. 5.
[0054] Note that the arrow pointing to the bar graph in FIG. 5 and the letters “yellow-green” and “yellow” are written for convenience to explain the color of the bar graph, and are not displayed on the medication status display screen 124.
[0055] In addition, the method of changing the display mode when the actual dose reaches the target dose and when it does not reach the target dose is not limited to the example of this embodiment. For example, various methods can be adopted depending on the type of disease targeted by the treatment support system 100 and the age group of the patient. For example, when the actual dose reaches the target dose, the display part of the actual dose may be displayed as a lit-up display, and when it does not reach the target dose, it may be displayed as a blinking display. Alternatively, when the actual dose reaches the target dose, a mark imitating a smiling face may be displayed, and when it does not reach the target dose, a mark imitating a sad face may be displayed.
[0056] 5, when the input unit 11 accepts a pressing operation of the first screen transition button 1231 or the third screen transition button 1233, the display on the patient-side display unit 12 transitions to either the biological information input screen 123 or the biological information transition screen 125. In the example of FIG. 5, it is assumed that the input unit 11 accepts a pressing operation of the third screen transition button 1233.
[0057] When the input unit 11 accepts the pressing operation of the third screen transition button 1233, the display of the patient-side display unit 12 transitions from the medication status display screen 124 to a biological information transition screen 125 shown in FIG. 6. The biological information transition screen 125 displays the transition of input values from a past input time point to the current input time point for various biological information input from the biological information input screen 123 in a graph form. That is, the patient-side display control unit 162 reads out the input values from a past input time point to the current input time point from the storage unit 31, and generates a graph showing the transition of these input values. Then, the patient-side display control unit 162 causes the patient-side display unit 12 to display the generated graph. In the example of FIG. 6, the transition of input values for each of "blood pressure value (maximum blood pressure value, minimum blood pressure value)", "body weight", and "pulse rate" from the beginning of the month to the end of the month is displayed in a graph form.
[0058] In the case where the biological information transition screen 125 is in the display mode shown in Fig. 6, when the input unit 11 accepts a pressing operation of the first screen transition button 1231 or the second screen transition button 1232, the display on the patient-side display unit 12 transitions to either the biological information input screen 123 or the medication status display screen 124. In the example of Fig. 6, it is assumed that the input unit 11 accepts a pressing operation of the first screen transition button 1231.
[0059] When the input unit 11 accepts the pressing operation of the first screen transition button 1231, the display of the patient-side display unit 12 transitions from the biological information transition screen 125 to the biological information input screen 123 again. The biological information input screen 123 is provided with a record button 1234 shown in FIG. 4, and when the input unit 11 accepts the pressing operation of the record button 1234, the contents of the patient information acquired by the decision unit 161 are confirmed and recorded in the storage unit 31. The "contents of the patient information" referred to here refers to the biological information of the patient (systolic blood pressure value, diastolic blood pressure value, pulse rate, and weight) input to the input unit 11. After the patient information is confirmed, the decision unit 161 receives the patient information transmitted from the input unit 11, and thereby the decision unit 161 acquires the patient information. After the decision unit 161 acquires the patient information, the process proceeds to S103.
[0060] <s103> Next, in S103, the doctor display control unit 251 switches the display mode of the doctor terminal 2 from the patient mode to the examination mode (mode switching step). It is assumed that the doctor display control unit 251 can display a patient mode screen on the doctor display unit 22. The display control of the patient mode screen by the doctor display control unit 251 is realized by the input unit 21 accepting a predetermined operation by the doctor.
[0061] Specifically, when the input unit 21 accepts a predetermined operation by the doctor, the doctor-side display control unit 251 causes the doctor-side display unit 22 to display the bioinformation input screen 123 indicated by reference numeral 701 in Fig. 7. Then, when the input unit 21 accepts a pressing operation of a mode switching button 1235 provided on the bioinformation input screen 123, the doctor-side display control unit 251 transitions the display on the doctor-side display unit 22 from the bioinformation input screen 123 to the authentication screen 221 indicated by reference numeral 702 in Fig. 7.
[0062] In this embodiment, the authentication screen 221 is provided with a password input field 2211, and the input unit 21 accepts password input from the password input field 2211. Here, only the doctor knows the password for screen transition to the examination mode. After accepting the password input, when the input unit 21 accepts the pressing operation of the login button 2212, the control unit 25 executes the authentication process. Then, when the authentication process of the control unit 25 is successful, the doctor-side display control unit 251 switches the display mode of the doctor-side terminal 2 from the patient mode to the examination mode. Specifically, the doctor-side display control unit 251 transitions the display of the doctor-side display unit 22 from the authentication screen 221 to the blood information input screen 222 shown by the reference numeral 703 in FIG. 7. When the display mode of the doctor-side terminal 2 is switched to the examination mode, the process proceeds to S104.
[0063] Although it is possible to display the authentication screen 221 on the patient-side display unit 12, since the patient does not know the password for transitioning the screen to the examination mode, it is practically impossible to switch the display mode on the patient-side terminal 1 to the examination mode.
[0064] <s104> Next, in S104, the decision unit 161 acquires blood information of the patient (blood information acquisition step). In this embodiment, the decision unit 161 acquires the creatinine amount and serum potassium value as the blood information of the patient. The blood information acquisition step is one example of realizing the decision step included in the treatment support method according to one aspect of the present invention. Note that, as a premise for the processing of S104, it is assumed that a blood test device (not shown) is installed in the hospital where the doctor works, and the patient undergoes a blood test using the blood test device.
[0065] Specifically, after the process of S103, a blood information input screen 222 shown by reference numeral 801 in Fig. 8 is displayed on the doctor's display unit 22. The blood information input screen 222 automatically displays the date and time of input, and also has columns for "Cre (creatinine amount)" and "K (serum potassium level)." The input unit 21 accepts input operations into these columns, whereby the patient's blood information is input into the input unit 21. This input operation is performed by a doctor who has grasped the results of the blood test described above.
[0066] Furthermore, blood information input screen 222 is provided with send button 2221 and mode end button 2222. When input unit 21 accepts a pressing operation of send button 2221, it transmits the input blood information to determination unit 161. Determination unit 161 receives the blood information transmitted from input unit 21, thereby acquiring the blood information.
[0067] However, the blood test equipment may transmit the patient's blood information directly to decision unit 161 without going through input unit 21, so that decision unit 161 may acquire the blood information. Alternatively, blood information input screen 222 may be displayed on patient-side display unit 12 as a patient mode screen, and input unit 11 may accept an input operation of the patient's blood information. In other words, the patient may input his or her own blood information from patient-side terminal 1. In this case, decision unit 161 acquires the patient's blood information from input unit 11.
[0068] When the determination unit 161 acquires the blood information of the patient, the process proceeds to S105. On the other hand, when the input unit 21 accepts a pressing operation of the mode end button 2222, the doctor-side display control unit 251 transitions the display of the doctor-side display unit 22 from the blood information input screen 222 to a patient mode screen or a home screen (not shown).
[0069] Here, a fourth screen transition button 2223, a fifth screen transition button 2224, and a sixth screen transition button 2225 are provided in the lower end area of the blood information input screen 222. When the input unit 21 accepts a pressing operation of the fourth screen transition button 2223 in a case where the display mode of the doctor side terminal 2 is the examination mode, the doctor side display control unit 251 transitions the display of the doctor side display unit 22 to the blood information input screen 222. When the input unit 21 accepts a pressing operation of the fifth screen transition button 2224, the doctor side display control unit 251 transitions the display of the doctor side display unit 22 to the adjustment content display screen 223 described later. When the input unit 21 accepts a pressing operation of the sixth screen transition button 2225, the doctor side display control unit 251 transitions the display of the doctor side display unit 22 to the dosage input screen 224 described later. The fourth to sixth screen transition buttons 2223 to 2225 are also displayed in the bottom areas of the adjustment content display screen 223 and the dosage input screen 224.
[0070] <S105からS113> Next, in S105 to S113, the determination unit 161 determines the adjustment content of the medicine dosage prescribed to the patient based on the acquired patient information and blood information (adjustment content determination step). The adjustment content determination step is one implementation example of the determination step included in the medical treatment support method according to one aspect of the present invention.
[0071] In this embodiment, the determination unit 161 determines the adjustment content of the drug dosage to be either increase, maintenance, decrease, or "0 (zero)". The adjustment content "0 (zero)" means the discontinuation of drug treatment. However, there is no particular limitation on the adjustment content determined by the determination unit 161. For example, even if the increase or decrease is the same, the determination unit 161 may determine the increase or decrease of the total dosage, or may determine the increase or decrease of the dosage per dose. In addition, in this embodiment, the determination unit 161 determines the adjustment content in accordance with the "Guidelines for the Treatment of Acute and Chronic Heart Failure (Revised Edition 2017)" issued by the Japanese Circulation Society. Each process from S105 to S113 in the flowchart of FIG. 2 is in accordance with this publicly known guideline, and therefore the description thereof will be omitted.
[0072] However, the method of determining the adjustment contents by the determination unit 161 is not limited to the example of this embodiment. For example, the determination unit 161 may determine the adjustment contents according to a known guideline other than the "Acute and Chronic Heart Failure Medical Care Guideline", or may determine the adjustment contents according to a guideline created independently by a doctor or the like. Alternatively, the adjustment contents may be determined by acquiring the adjustment contents output from a learning model constructed in advance. In this case, the patient information and blood information acquired by the determination unit 161 are input to the learning model. In addition, the learning model is constructed by machine learning using a data set of past patient information and blood information regarding a plurality of patients and the adjustment contents finally determined by a doctor as teacher data.
[0073] After determining the adjustment content, the determination section 161 transmits the determination result to the patient-side display control section 162. When the transmission of the determination result by the determination section 161 is completed, the process proceeds to S114.
[0074] <s114> Next, in S114, the patient-side display control unit 162 displays the determination result (adjustment of the drug dosage) of the determination unit 161 on both the patient-side display unit 12 and the doctor-side display unit 22. The process of S114 is an example of realizing a display control step included in the treatment support method according to one aspect of the present invention.
[0075] Specifically, by receiving the determination result transmitted from the determination unit 161, the patient-side display control unit 162 transitions the display on the patient-side display unit 12 from any of the patient mode screens to the adjustment content display screen 223 indicated by reference numeral 802 in Fig. 8. Then, the patient-side display control unit 162 displays the determination result of the determination unit 161 on the adjustment content display screen 223. In other words, it is substantially impossible to switch the display mode to the examination mode on the patient-side terminal 1, but among the various screens displayed in the examination mode, only the adjustment content display screen 223 can be displayed on the patient-side display unit 12 as well.
[0076] The adjustment content display screen 223 has substantially the same screen configuration as the dosage status display screen 124 shown in Fig. 5. In addition, adjustment content indicators 2231 to 2233 are displayed near the bar graphs relating to the dosages of the ACE inhibitor / ARB / ARNI, β-blocker, and MRA displayed on the adjustment content display screen 223. The adjustment content indicators 2231 to 2233 are indicators that represent the determination results of the determination unit 161, that is, the dosage adjustment contents, for each of the ACE inhibitor / ARB / ARNI, β-blocker, and MRA.
[0077] In this embodiment, the adjustment content indicators 2231 to 2233 are composed of words and arrows that simply indicate the contents of "increase", "decrease", and "maintain", as shown by reference numeral 802 in Fig. 8. Furthermore, although not shown, when drug treatment is discontinued, the adjustment content indicators 2231 to 2233 are composed of words and arrows that simply indicate the contents of "discontinue". Of course, the display form of the adjustment content indicators 2231 to 2233 is not limited to the example of reference numeral 802 in Fig. 8, but it is preferable that the configuration be easy for patients to understand.
[0078] Furthermore, by receiving the determination result transmitted from the determination unit 161, the patient-side display control unit 162 transitions the display on the doctor-side display unit 22 from the blood information input screen 222 to the adjustment content display screen 223. Then, the patient-side display control unit 162 causes the doctor-side display unit 22 to display the determination result of the determination unit 161. In other words, the patient-side display control unit 162 can also control the display on the doctor-side display unit 22 via the communication units 14 and 24. When the input unit 21 accepts the pressing operation of the sixth screen transition button 2225 on the adjustment content display screen 223, the process proceeds to S115.
[0079] <s115> Next, in S115, the storage unit 31 updates the current dosage among the patient information recorded in the storage unit 31 (data update step). Specifically, after the process of S114, the display on the doctor's side display unit 22 transitions from the adjustment content display screen 223 to the dosage input screen 224 shown by reference numeral 803 in FIG. 8. The dosage input screen 224 is provided with dosage input fields 2241 to 2243 for inputting new dosages for each of the ACE inhibitor / ARB / ARNI, β-blocker, and MRA. The "new dosage" refers to the dosage that is finally determined by the doctor and the patient through consultation and mutual agreement based on the determination result of the determination unit 161.
[0080] A new dose is input to the input unit 21 by the input unit 21 accepting an input operation into the dose input fields 2241 to 2243. Then, the input unit 21 accepts a pressing operation of the decision button 2244 provided on the dose input screen 224, so that the numerical value input to the input unit 21 is confirmed as the new dose. Once the numerical value of the new dose is confirmed, the input unit 21 transmits information indicating the new dose to the storage unit 31. The storage unit 31, which has received the information indicating the new dose, updates the current dose in the patient information to the new dose based on the information. The update of the current dose completes the process of S115, and a series of processes by the medical treatment support system 100 is completed.
[0081] [Modifications] The contents and order of various processes, the configurations of various screens, the flow of screen transitions, etc. shown in Figures 2 to 8 are merely examples, and various variations can be adopted. Some variations will be described below as examples.
[0082] First, it is not essential that the patient-side display control unit 162 causes the patient-side display unit 12 to display the actual dose and the target dose. Also, it is not essential that the patient-side display control unit 162 causes the doctor-side display unit 22 to display the decision result of the decision unit 161. It is sufficient that the patient-side display control unit 162 at least causes the patient-side display unit 12 to display the decision result of the decision unit 161.
[0083] Next, in this embodiment, the patient-side display control unit 162 causes the doctor-side display unit 22 to display the decision result of the decision unit 161, but the doctor-side display control unit 251 may also cause the doctor-side display unit 22 to display the decision result of the decision unit 161. In other words, the patient-side display control unit 162 and the doctor-side display control unit 251 may constitute a display control unit according to one aspect of the present invention. In this case, the patient-side display control unit 162 transmits a request signal indicating the decision result of the decision unit 161 and a display request to the doctor-side display control unit 251 via the communication units 14 and 24. By receiving the decision result of the decision unit 161 and the request signal, the doctor-side display control unit 251 causes the doctor-side display control unit 251 to display the decision result.
[0084] Next, in this embodiment, the patient-side display control unit 162 displays the patient's biological information only on the patient-side display unit 12 (see reference numeral 402 in FIG. 4), but the biological information may be displayed on both the patient-side display unit 12 and the doctor-side display unit 22. In this case, the patient-side display control unit 162 may display, for example, the biological information input screen 123 after data input on the doctor-side display unit 22.
[0085] Next, the patient-side display control unit 162 may convert the result of the decision made by the decision unit 161 into content suitable for presentation to the patient and display it on the patient-side display unit 12. "Content suitable for presentation to the patient" refers to content that indicates a specific response that the patient should take or is preferable to take, in an easy-to-understand manner for the patient and in an expression that takes into consideration the patient's health condition and psychological state. Specific examples of "content suitable for presentation to the patient" include "Let's discuss the amount of medicine at the next appointment," "It looks like you're doing well! At the next appointment, you may want to discuss increasing the amount of medicine to speed up the goal achievement," and the like. In addition, the patient-side display control unit 162 or the doctor-side display control unit 251 may convert the result of the decision made by the decision unit 161 into content suitable for presentation to the doctor and display it on the doctor-side display unit 22. "Content suitable for presentation to the doctor" refers to content that the doctor can immediately recall a specific response based on his / her professional knowledge. Specific examples of "content suitable for presentation to the doctor" include "Let's consider increasing / reducing the amount of the drug," "Let's consider ceasing the drug treatment," and the like.
[0086] Next, the determination unit 161 may refer to the patient-reported outcomes of the patient when determining the adjustment of the drug dosage. In other words, the patient information, which is reference information when the determination unit 161 determines the adjustment, may include the patient-reported outcomes of the patient. A patient-reported outcome is any report on the health condition of the patient obtained directly from the patient without any interpretation by a doctor, clinician, or anyone else. Specific examples of patient-reported outcomes include subjective symptoms such as leg edema, shortness of breath, pain, breathlessness, and fatigue, and the patient's subjective opinion on physical functions such as walking.
[0087] [Software implementation example] The functions of the treatment support device 16 (hereinafter referred to as the "device") can be realized by a program for causing a computer to function as the device, and a program for causing a computer to function as each control block of the device (particularly each part included in the control unit 15).
[0088] In this case, the device includes a computer having at least one control device (e.g., a processor) and at least one storage device (e.g., a memory) as hardware for executing the program. The control device and storage device execute the program to realize each function described in each embodiment.
[0089] The program may be non-transitory and may be recorded in one or more computer-readable recording media. The recording media may or may not be included in the device. In the latter case, the program may be provided to the device via any wired or wireless transmission medium.
[0090] In addition, some or all of the functions of each of the control blocks can be realized by a logic circuit. For example, an integrated circuit in which a logic circuit that functions as each of the control blocks is formed is also included in the scope of the present invention. In addition, the functions of each of the control blocks can be realized by, for example, a quantum computer.
[0091] [Additional Notes] The present invention is not limited to the above-described embodiments, and various modifications are possible within the scope of the claims. Embodiments obtained by appropriately combining the technical means disclosed in different embodiments are also included in the technical scope of the present invention. [Explanation of symbols]
[0092] 1. Patient terminal (terminal used by the patient) 2 Doctor's terminal (terminal used by the doctor) 12 Patient side display 16 Treatment support equipment 22 Doctor's display unit 161 Decision Section 162 Patient side display control unit (display control unit)
Claims
1. A determination unit that determines the adjustment content of the drug dosage by acquiring patient information including biological information of a patient and an actual dosage of the drug prescribed to the patient; A treatment support device comprising: a display control unit that displays the decision result of the decision unit on a patient side display unit, which is a display unit of a terminal used by the patient.
2. The display control unit is The patient-side display unit further displays the actual dose and the target dose of the drug set for the patient; 2. The treatment support device according to claim 1, wherein a display mode of the actual dose on the patient-side display unit is changed depending on whether the actual dose has reached the target dose.
3. The treatment support device according to claim 1 , wherein the display control unit also displays the determination result on a doctor's display unit which is a display unit of a terminal used by the doctor.
4. The treatment support device according to claim 3 , wherein the display control unit causes the biological information to be displayed on both the patient-side display unit and the doctor-side display unit.
5. The treatment support device according to claim 1 , wherein the display control unit converts the determination result into content suitable for presentation to the patient and displays the content on the patient-side display unit.
6. The medical treatment support device according to claim 1 , wherein the biological information includes blood information of the patient.
7. The therapeutic support device according to claim 1 , wherein the patient information further includes a patient-reported outcome of the patient.
8. A program for causing a computer to function as the treatment support device according to claim 1 , the program causing a computer to function as the determination unit and the display control unit.
9. A determination step of determining an adjustment content of the drug dosage by acquiring patient information including a patient's biological information and an actual dosage of the drug prescribed to the patient; A treatment support method comprising: a display control step of displaying the result of the determination in the determination step on a patient side display unit, which is a display unit of a terminal used by the patient.
Citation Information
Patent Citations
Medical care assistance system, medical care assistance device, medical care assistance method and program
JP2023010391A